Catalyst Pharmaceuticals (CPRX) P/E Ratio
P/E Ratio as of Jul 2, 2025: 13.69
Average15.02
Median14.92
Minimum13.52
Maximum16.79
13.69
Past Month-2.24 (14.06%)
The P/E ratio for Catalyst Pharmaceuticals (CPRX) is 13.69 as of Jul 2, 2025. This represents a decrease of -32.89% compared to its 12-month average P/E ratio of 20.4. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
Catalyst Pharmaceuticals P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Catalyst Pharmaceuticals’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Catalyst Pharmaceuticals to industry peers.
Catalyst Pharmaceuticals P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Catalyst Pharmaceuticals’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Catalyst Pharmaceuticals to industry peers.
Catalyst Pharmaceuticals (CPRX) P/E Ratio Insights
See Catalyst Pharmaceuticals’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in Catalyst Pharmaceuticals (CPRX)
Order type
Buy in
Order amount
Est. shares
0 shares
Catalyst Pharmaceuticals (CPRX) P/E Ratio Historic Data
| Date | Stock price | P/E ratio |
|---|---|---|
| Jul 1, 2025 | $21.19 | 13.52 |
| Jun 2, 2025 | $24.90 | 15.89 |
| May 1, 2025 | $24.27 | 18.55 |
| Apr 1, 2025 | $23.92 | 18.28 |
| Mar 3, 2025 | $22.32 | 17.06 |
| Feb 3, 2025 | $22.62 | 19.30 |
| Jan 2, 2025 | $21.52 | 18.36 |
Catalyst Pharmaceuticals (CPRX) End of Year P/E Ratio
| Date | P/E ratio | Change |
|---|---|---|
| 2025 | 13.69 | -23.13% |
| 2024 | 17.81 | -44.13% |
| 2023 | 31.88 | +4.18% |
| 2022 | 30.60 | +65.49% |
| 2021 | 18.49 | +290.08% |
| 2020 | 4.74 | — |
FAQs About Catalyst Pharmaceuticals (CPRX) P/E ratio
The latest P/E ratio of Catalyst Pharmaceuticals (CPRX) is 13.69, as of Jul 2, 2025. This is calculated based on its current stock price and earnings per share (EPS).
Catalyst Pharmaceuticals’s last 12-month average P/E ratio is 20.4, compared to its current P/E ratio of 13.69. This reflects a decrease of -32.89%.
Catalyst Pharmaceuticals’s current P/E ratio of 13.69 is lower than its last 12-month average P/E of 20.4. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
Catalyst Pharmaceuticals’s average P/E ratio over the last 3 years is 22.03. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
Catalyst Pharmaceuticals’s average P/E ratio over the last 5 years is 17.69. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.